One- Versus Three-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease.
Mankerious N, Toelg R, Vogel B, Sartori S, Angiolillo DJ, Vranckx P, Feng Y, Hernandez JMT, Krucoff MW, Bhatt DL, Spirito A, Cao D, Chehab BM, Kunadian V, Maksoud A, Picon H, Sardella G, Thiele H, Varenne O, Windecker S, Richardt G, Valgimigli M, Mehran R.
Mankerious N, et al. Among authors: hernandez jmt.
Am J Cardiol. 2024 Jun 11:S0002-9149(24)00425-9. doi: 10.1016/j.amjcard.2024.06.003. Online ahead of print.
Am J Cardiol. 2024.
PMID: 38871156